Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03829436 |
Title | TPST-1120 as Monotherapy and in Combination With (Nivolumab, Docetaxel or Cetuximab) in Subjects With Advanced Cancers |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Tempest Therapeutics |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California - San Francisco | San Francisco | California | 94158 | United States | Details | |
Miami Cancer Institute | Miami | Florida | 33176 | United States | Details | |
Johns Hopkins University | Baltimore | Maryland | 21287 | United States | Details | |
University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
Columbia University Medical Center | New York | New York | 10024 | United States | Details | |
Carolina BioOncology Institute | Huntersville | North Carolina | 28078 | United States | Details | |
Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
University of Pennsylvania Perelman School of Medicine | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | United States | Details | |
UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15213 | United States | Details | |
Sarah Cannon Research Institute - TN | Nashville | Tennessee | 37203 | United States | Details |